US2015118178A1PendingUtilityA1

Conjugates comprising an n-oxime bond and associated methods

Assignee: UNIV KANSASPriority: Jun 24, 2010Filed: Dec 31, 2014Published: Apr 30, 2015
Est. expiryJun 24, 2030(~3.9 yrs left)· nominal 20-yr term from priority
A61K 39/0008A61K 2039/627A61K 39/385C07B 43/00A61K 47/549A61K 2039/6093A61K 47/61A61K 31/436A61K 47/6933A61K 47/48176A61K 47/4823A61K 47/48092A61K 47/6937A61K 47/593A61K 47/6939
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Conjugates comprising a N-oxime bond are disclosed. In one embodiment, a suitable conjugate is represented by the following Formula (I): wherein R′ is derived from a compound comprising at least one reactive amide group, R″ is derived from a compound comprising at least one reactive aminooxy group, and X is H, C n H (n+2) or other atoms. Additional methods are also provided.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising a conjugate represented by the following Formula (I): 
       
         
           
           
               
               
           
         
         wherein R′ is derived from a first compound comprising at least one reactive amide group, R″ is derived from a second compound comprising at least one reactive aminooxy group, wherein the second compound is selected from the group consisting of a polymer, a polysaccharide, a saccharide, a nucleic acid and a small molecule, and X is H, C n H (n+2) . 
       
     
     
         2 . The composition of  claim 1  further comprising at least one additional N-oxime bond so as to form a crosslinked composition. 
     
     
         3 . The composition of  claim 1  wherein the first compound is selected from the group consisting of a polymer, a protein, a peptide, a polysaccharide, a saccharide, a nucleic acid and a small molecule. 
     
     
         4 . The composition of  claim 1  further comprising a pharmaceutically acceptable carrier. 
     
     
         5 . A composition comprising a conjugate represented by the following Formula (II): 
       
         
           
           
               
               
           
         
         wherein R′ is derived from a first compound comprising at least one reactive amide group, R″ is derived from a second compound comprising at least one reactive aminooxy group, wherein the second compound is selected from the group consisting of a polymer, a polysaccharide, a saccharide, a nucleic acid and a small molecule, and X is H, C n H (n+2) . 
       
     
     
         6 . The composition of  claim 5  further comprising at least one additional N-oxime bond so as to form a crosslinked composition. 
     
     
         7 . The composition of  claim 5  wherein the first compound is selected from the group consisting of a polymer, a protein, a peptide, a polysaccharide, a saccharide, a nucleic acid and a small molecule. 
     
     
         8 . The composition of  claim 5  further comprising a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2015118178A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.